PubRank

Harran Mkocha

Author PubWeight™ 41.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Strategies for control of trachoma: observational study with quantitative PCR. Lancet 2003 3.40
2 Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005 2.62
3 Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci 2005 1.94
4 Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial. PLoS Negl Trop Dis 2010 1.81
5 Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment. Clin Infect Dis 2013 1.71
6 Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci 2005 1.62
7 Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. Invest Ophthalmol Vis Sci 2007 1.43
8 CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis 2012 1.40
9 Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania. J Infect Dis 2011 1.32
10 Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial. Lancet 2006 1.20
11 Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci 2011 1.18
12 Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania. PLoS Negl Trop Dis 2011 1.18
13 Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children. Am J Trop Med Hyg 2011 1.09
14 Issues in defining and measuring facial cleanliness for national trachoma control programs. Trans R Soc Trop Med Hyg 2008 1.07
15 Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children. Pediatr Infect Dis J 2012 1.07
16 Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania. Ophthalmology 2008 1.02
17 Mass treatment with azithromycin for trachoma control: participation clusters in households. PLoS Negl Trop Dis 2010 1.02
18 Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. BMC Infect Dis 2014 1.00
19 Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity. PLoS Negl Trop Dis 2013 0.98
20 A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma. PLoS Negl Trop Dis 2013 0.97
21 Field evaluation of the Cepheid GeneXpert Chlamydia trachomatis assay for detection of infection in a trachoma endemic community in Tanzania. PLoS Negl Trop Dis 2013 0.96
22 Age, sex, and cohort effects in a longitudinal study of trachomatous scarring. Invest Ophthalmol Vis Sci 2008 0.94
23 Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control? J Infect Dis 2014 0.92
24 Azithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment rounds. PLoS Negl Trop Dis 2012 0.92
25 Change in function and spectacle-use 2 months after providing presbyopic spectacles in rural Tanzania. Br J Ophthalmol 2010 0.88
26 Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma? Invest Ophthalmol Vis Sci 2011 0.87
27 Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control. Ophthalmic Epidemiol 2015 0.86
28 Randomized trial of high dose azithromycin compared to standard dosing for children with severe trachoma in Tanzania. Ophthalmic Epidemiol 2009 0.86
29 Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment. Invest Ophthalmol Vis Sci 2006 0.86
30 Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results. JAMA Ophthalmol 2013 0.85
31 Trends in weekly reported net use by children during and after rainy season in central Tanzania. Malar J 2012 0.80
32 Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania. Ophthalmic Epidemiol 2012 0.80
33 A cross-sectional survey of water and clean faces in trachoma endemic communities in Tanzania. BMC Public Health 2011 0.80
34 Cohort and age effects of mass drug administration on prevalence of trachoma: a longitudinal study in rural Tanzania. Invest Ophthalmol Vis Sci 2014 0.79
35 Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining. PLoS Negl Trop Dis 2015 0.75